Jeff Castelli - 11 Jan 2023 Form 4 Insider Report for AMICUS THERAPEUTICS, INC. (FOLD)

Reporting relationship: Chief Development Officer
Issuer ticker: FOLD
Reported as of: 11 Jan 2023
Net transaction value: -$292,386
SEC form: 4
Accepted by SEC: 13 Jan 2023, 16:11:24 UTC
Prior SEC filing: 06 Jan 2023
Next SEC filing: 21 Aug 2023
Source filing: View source filing
Reporting owner signature: /s/ Christian Formica, Attorney-in-Fact

Filing notes and source

Key filing fact

Jeff Castelli filed Form 4 for AMICUS THERAPEUTICS, INC. (FOLD) on 13 Jan 2023.

Key facts

This page summarizes Jeff Castelli's Form 4 filing for AMICUS THERAPEUTICS, INC. (FOLD).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 13 Jan 2023, 16:11.

Change

Previous filing in this sequence was filed on 06 Jan 2023.
Current net transaction value: -$292,386.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

FOLD transaction

Common Stock

Award

Transaction value: $0
Shares: +56,024
Change %: +16%
Price: $0.000000
Shares after: 407,478
Date: 11 Jan 2023
Ownership: Direct
Footnotes: F1

FOLD transaction

Common Stock

Tax liability

Transaction value: -$292,386
Shares: -24,325
Change %: -6%
Price: $12.02
Shares after: 383,153
Date: 11 Jan 2023
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Granted for the achievement of the 2020 PRSU TSR goal as determined by the Compensation and Leadership Development Committee of the Board of Directors.